Investigating the analgesia effect of pudendal block with placebo after pelvic floor prolapse surgeries

Comparison of the analgesia effect of perineal nerve blockage with marcaine with placebo after pelvic floor prolapse surgeries

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231025059847N1

Enrollment

Registered

2023-11-09

Start date

2023-11-11

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic floor prolapse surgeries. Incomplete uterovaginal prolapse

Interventions

Intervention 1: Intervention group: Women undergoing pelvic floor prolapse surgery, 30-80 years old, for whom pudendal block is performed as follows: 2 cc of Marcaine 7.5 mg/ml aspen group of companie

Eligibility

Sex/Gender

Female

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Women undergoing pelvic floor prolapse surgery

Exclusion criteria

Exclusion criteria: History of chronic pelvic pain History of hypersensitivity to blocking drugs, narcotics or analgesics Chronic use of analgesics or narcotics Patients suffering from liver or kidney problems Patients with simultaneous abdominal or laparoscopic surgery

Design outcomes

Primary

Measure	Time frame
Pain level after surgery. Timepoint: The day after the surgery. Method of measurement: Visual analogue scale.;Nausea. Timepoint: The day after the surgery. Method of measurement: Asking the patient how often she feels nausea.;Number of analgesics used. Timepoint: The day after the surgery. Method of measurement: Checking the number of analgesics requests in the file.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamide Nematian

Tehran University of Medical Sciences

hnematian6173@gmail.com+98 21 6119 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026